258 related articles for article (PubMed ID: 37566109)
1. A novel role for PGE
Yarboro MT; Boatwright N; Sekulich DC; Hooper CW; Wong T; Poole SD; Berger CD; Brown AJ; Jetter CS; Sucre JMS; Shelton EL; Reese J
Am J Physiol Heart Circ Physiol; 2023 Oct; 325(4):H687-H701. PubMed ID: 37566109
[TBL] [Abstract][Full Text] [Related]
2. Isoprostanes as physiological mediators of transition to newborn life: novel mechanisms regulating patency of the term and preterm ductus arteriosus.
Chen JX; O'Mara PW; Poole SD; Brown N; Ehinger NJ; Slaughter JC; Paria BC; Aschner JL; Reese J
Pediatr Res; 2012 Aug; 72(2):122-8. PubMed ID: 22565502
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandin E-mediated molecular mechanisms driving remodeling of the ductus arteriosus.
Yokoyama U
Pediatr Int; 2015 Oct; 57(5):820-7. PubMed ID: 26228894
[TBL] [Abstract][Full Text] [Related]
4. PGE2 through the EP4 receptor controls smooth muscle gene expression patterns in the ductus arteriosus critical for remodeling at birth.
Gruzdev A; Nguyen M; Kovarova M; Koller BH
Prostaglandins Other Lipid Mediat; 2012 Mar; 97(3-4):109-19. PubMed ID: 22342504
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin E
Sakuma T; Akaike T; Minamisawa S
Circ J; 2018 Dec; 83(1):209-216. PubMed ID: 30416151
[TBL] [Abstract][Full Text] [Related]
6. Fibulin-1 Integrates Subendothelial Extracellular Matrices and Contributes to Anatomical Closure of the Ductus Arteriosus.
Ito S; Yokoyama U; Nakakoji T; Cooley MA; Sasaki T; Hatano S; Kato Y; Saito J; Nicho N; Iwasaki S; Umemura M; Fujita T; Masuda M; Asou T; Ishikawa Y
Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):2212-2226. PubMed ID: 32640908
[TBL] [Abstract][Full Text] [Related]
7. Chronic activation of the prostaglandin receptor EP4 promotes hyaluronan-mediated neointimal formation in the ductus arteriosus.
Yokoyama U; Minamisawa S; Quan H; Ghatak S; Akaike T; Segi-Nishida E; Iwasaki S; Iwamoto M; Misra S; Tamura K; Hori H; Yokota S; Toole BP; Sugimoto Y; Ishikawa Y
J Clin Invest; 2006 Nov; 116(11):3026-34. PubMed ID: 17080198
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E2 inhibits elastogenesis in the ductus arteriosus via EP4 signaling.
Yokoyama U; Minamisawa S; Shioda A; Ishiwata R; Jin MH; Masuda M; Asou T; Sugimoto Y; Aoki H; Nakamura T; Ishikawa Y
Circulation; 2014 Jan; 129(4):487-96. PubMed ID: 24146253
[TBL] [Abstract][Full Text] [Related]
9. [A new therapeutic target for patent ductus arteriosus].
Ito S; Yokoyama U
Nihon Yakurigaku Zasshi; 2021; 156(6):359-363. PubMed ID: 34719570
[TBL] [Abstract][Full Text] [Related]
10. Mouse models of patent ductus arteriosus (PDA) and their relevance for human PDA.
Yarboro MT; Gopal SH; Su RL; Morgan TM; Reese J
Dev Dyn; 2022 Mar; 251(3):424-443. PubMed ID: 34350653
[TBL] [Abstract][Full Text] [Related]
11. Patent ductus arteriosus and neonatal death in prostaglandin receptor EP4-deficient mice.
Segi E; Sugimoto Y; Yamasaki A; Aze Y; Oida H; Nishimura T; Murata T; Matsuoka T; Ushikubi F; Hirose M; Tanaka T; Yoshida N; Narumiya S; Ichikawa A
Biochem Biophys Res Commun; 1998 May; 246(1):7-12. PubMed ID: 9600059
[TBL] [Abstract][Full Text] [Related]
12. The paradoxical patent ductus arteriosus.
Ivey KN; Srivastava D
J Clin Invest; 2006 Nov; 116(11):2863-5. PubMed ID: 17080192
[TBL] [Abstract][Full Text] [Related]
13. Role of prostaglandin E and its receptors in the process of ductus arteriosus maturation and functional closure in the rabbit.
Fan FL; Zhu S; Chen LH; Zou YL; Fan LH; Kang JH; Ma AQ; Guan YF
Clin Exp Pharmacol Physiol; 2010 May; 37(5-6):574-80. PubMed ID: 20082631
[TBL] [Abstract][Full Text] [Related]
14. Understanding the pathobiology in patent ductus arteriosus in prematurity-beyond prostaglandins and oxygen.
Hundscheid T; van den Broek M; van der Lee R; de Boode WP
Pediatr Res; 2019 Jul; 86(1):28-38. PubMed ID: 30965358
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin E2--mediated relaxation of the ductus arteriosus: effects of gestational age on g protein-coupled receptor expression, signaling, and vasomotor control.
Waleh N; Kajino H; Marrache AM; Ginzinger D; Roman C; Seidner SR; Moss TJ; Fouron JC; Vazquez-Tello A; Chemtob S; Clyman RI
Circulation; 2004 Oct; 110(16):2326-32. PubMed ID: 15477420
[TBL] [Abstract][Full Text] [Related]
16. Attenuated cyclooxygenase-2 expression contributes to patent ductus arteriosus in preterm mice.
Trivedi DB; Sugimoto Y; Loftin CD
Pediatr Res; 2006 Dec; 60(6):669-74. PubMed ID: 17065565
[TBL] [Abstract][Full Text] [Related]
17. [A study for functions of prostaglandin E receptor EP4 subtype by analysing knockout mice].
Segi E
Yakugaku Zasshi; 2001 Jan; 121(1):35-45. PubMed ID: 11201161
[TBL] [Abstract][Full Text] [Related]
18. Chronic in utero cyclooxygenase inhibition alters PGE2-regulated ductus arteriosus contractile pathways and prevents postnatal closure.
Reese J; Waleh N; Poole SD; Brown N; Roman C; Clyman RI
Pediatr Res; 2009 Aug; 66(2):155-61. PubMed ID: 19390487
[TBL] [Abstract][Full Text] [Related]
19. Effect of PGE2 on DA tone by EP4 modulating Kv channels with different oxygen tension between preterm and term.
Fan F; Ma A; Guan Y; Huo J; Hu Z; Tian H; Chen L; Zhu S; Fan L
Int J Cardiol; 2011 Feb; 147(1):58-65. PubMed ID: 19729212
[TBL] [Abstract][Full Text] [Related]
20. Effects of Advancing Gestation and Non-Caucasian Race on Ductus Arteriosus Gene Expression.
Waleh N; Barrette AM; Dagle JM; Momany A; Jin C; Hills NK; Shelton EL; Reese J; Clyman RI
J Pediatr; 2015 Nov; 167(5):1033-41.e2. PubMed ID: 26265282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
